Archive: Company News

Company News: BellaSeno’s Senella® Medical Implant Technology Named a Bronze Winner of the 2020 Edison Awards

BellaSeno GmbH, an ISO 13485-certified medtech company developing absorbable scaffolds using additive manufacturing technologies, today announced that its Senella®  implant technology has won a Bronze Edison Award 2020 in the category Medical / Dental, subcategory Medical Implants.

Read more…

Company News: Curetis Begins Offering BGI’s CE-IVD Rapid Test Kit for Coronavirus in Europe

– Rapid real-time PCR test allows testing for SARS-CoV2 in only a few hours
– Test kit to be made available via Curetis’ European sales channels
– Synergies with Curetis Unyvero HPN panel for pneumonia testing for bacterial co-infections in Covid-19 patients
 

Curetis N.V. (the “Company” and together with its subsidiaries “Curetis”), a developer of next-level molecular diagnostic solutions, today announced that it starts offering a CE-IVD certified real-time PCR test kit for SARS-CoV2 (also known as 2019-nCov), the causal pathogen of Corona Virus Disease 2019 (Covid-19).

Read more…

Company News: Curetis Announces Preliminary, Unaudited 2019 Condensed Combined Key Financials and Provides Business Update

— Revenue increases by 64% to EUR 2.3 million, up from 1.4 million in 2018

— More than tripled total contract order volume received year-over-year to about EUR 3.4 million 2019

— Curetis N.V. shareholders to vote on March 10, 2020 on planned business combination with OpGen, Inc.

Curetis N.V. (the “Company” and, together with its subsidiaries, “Curetis“), a developer of next-level molecular diagnostic solutions, today announced preliminary. unaudited condensed combined key financials for the fiscal year 2019 and provided a business update for 2020 year-to-date.

Read more…

Company News: Curetis and Quaphaco Enter into Unyvero Distribution Partnership for Vietnam

— Exclusive distribution agreement for initial term of 3 years

— Quaphaco commits to minimum purchase totaling about
EUR 1.9 million during initial term

Curetis N.V. (the “Company” and, together with its subsidiaries, “Curetis“), a developer of next-level molecular diagnostic solutions, today announced that it has entered into a distribution agreement with Quaphaco for Vietnam. Quaphaco, headquartered in Ho Chi Minh City, is a leading medical equipment supplier in Vietnam that is already working with numerous renowned global IVD manufacturers.

Read more…

1 2 3 123